CLEAR·OCEAN

Capricor Therapeutics, Inc. (CAPR) — Insider Activity & Signal

Healthcare · Biotechnology · Market cap $380M · $6.57 · 52-week range $4.30–$40.37

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

No qualifying open-market insider purchases on file in the last six months.

Financial health

Altman Z-Score 3.13 · Piotroski F-Score 3/9 · Cash $318M · Debt $18M

ClearOcean signal read

ClearOcean's model currently scores CAPR as a watchlist-level signal (5/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Last updated July 30, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.